Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ergoferon Liquid for Acute URTI in Adults
NCT01765920Phase 3Completed
- Sponsor
- Materia Medica Holding
- Start
- Dec 2012
- Primary completion
- Dec 2014
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of Ergoferon in acute upper respiratory tract infection (URI), sponsored by Materia Medica Holding. Started Dec 2012; status: completed.
02
Drugs
Ergoferon
03
Conditions
acute upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT01765920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765920.